Investing Profile

George Zachary

VCInvestorAngel
General Partner at CRV
crv.com/team/george-zachary/Redwood City, California
Photo of George Zachary, General Partner at CRV
Silicon Graphics Network
14 CONNECTIONS
Mohr Davidow Ventures Network
12 CONNECTIONS
CRV Network
12 CONNECTIONS
StartX. Network
11 CONNECTIONS
cb
CRV General Partner
$500K - $20.0M
$13.0M
47
$600M
CompanyStageDateRound SizeTotal Raised
Glympse Bio
Series BJul 2020$47M
Series AOct 2018$22M
$76M
Co-investors: Amy Schulman (Polaris Partners), Theresia Gouw (aCrew Capital), Andrew Perlman (‎GreatPoint Ventures), Steve Kafka (Section 32)
System1 Biosciences
Series ASep 2018$25M
$25M
Co-investors: Courtney Broadus (Operator Collective)
Health IQ
Series CNov 2017$35M
Series BDec 2016$41M
SeedDec 2014$6M
$140M
Co-investors: Alex Rampell (Andreessen Horowitz), Pravin Vazirani (Owl Rock Capital Partners)
Wonder Workshop
Series COct 2017$41M
Series BJul 2016$20M
Series AMay 2015$7M
Series AMar 2014$8M
$77M
Co-investors: Vikas Gupta, Mikhail Seregine, Hemant Bhanoo
Zinc
Series UnknownApr 2017$11M
Series UnknownJun 2016$5M
$16M
Co-investors: Jason Green (Emergence Capital)
PillPack
Series DSep 2016$31M
Series CJun 2015$50M
$95M
Co-investors: David Frankel (Founder Collective), Brian Pham (Sherpa Ventures), Adam Rothenberg (BoxGroup), David Tisch (BoxGroup), Tyler Sosin (Menlo Ventures), Kevin Colleran (Slow Ventures), Aviad Eyal (Entrée Capital Ventures), Pravin Vazirani (Owl Rock Capital Partners), Scott Stanford (ACME Capital), Fred Destin (Stride VC), Jamie Goldstein (Pillar VC), Walter Winshall (Collaborative Seed & Growth Partners), Ken Loveless (Founders Circle Capital), Shervin Pishevar, Rashaun Williams
Udacity
Series DNov 2015$110M
Series CSep 2014$35M
Series BOct 2012$15M
Series AJan 2012$5M
$240M
Co-investors: Peter Levine (Andreessen Horowitz), Mark Kvamme (Drive Capital), Steve Blank (M34 Capital), Steve Kuo (Hercules Capital)
Scribd
Series DJan 2015$23M
Series CJan 2011$12M
Series BDec 2008$10M
$49M
Co-investors: Geoff Yang (Redpoint Ventures), Craig Sherman (Meritech Capital Partners), Jeff Jordan (Andreessen Horowitz), Marc Andreessen (Andreessen Horowitz), Keith Rabois (Khosla Ventures), David Sacks (Craft Ventures), Bill Tai
Deep learning / AI meets biology and chemistry. I am focused on products that accelerate breakthroughs in biological sciences that allow for new products that help peoples lives through huge advancements in health. An example investment we have made is in Freenome.
Not interested in anything outside of this area. Not interested in digital health that involves behavior modification programs.
Analyst Strategic Planning AssociatesPresent
Q&A to Sales C*ATS SoftwarePresent
Director, Sales, Marketing, Product VPL ResearchPresent
Nintendo 64 Silicon GraphicsPresent
General Partner Mohr Davidow VenturesPresent
General Partner CRVPresent
Director StartX.Present